Influence of HSA and IgG on LDL oxidation studied by size-exclusion chromatography and phospholipid profiling using MALDI tandem-mass spectrometry

Chemistry and Physics of Lipids

Volumn 164, Issue 6, 2011, Pages 563-572

  Stübiger, Gerald ^a   Sobal, Grazyna ^a   Widhalm, Kurt ^a   Belgacem, Omar ^b   Pock, Katharina ^c  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b Shimadzu   (United Kingdom)

^c Octapharma Pharmazeutika Produktions GmbH   (Austria)

Author keywords

Human serum albumin (HSA); Immunoglobulin G (IgG); Lyso phosphatidylcholine (LPC); MALDI (QIT) TOF MS( MS); Oxidized LDL (oxLDL); Size exclusion chromatography (SEC); Sphingomyelin (SM)

Indexed keywords

1 HEPTADECANOYL 2 HYDROXY SN GLYCERO 3 PHOSPHOCHOLINE; 1 LINOLENOYL 2 HYDROXY SN GLYCERO 3 PHOSPHOCHOLINE; 1 LINOLEOYL 2 HYDROXY SN GLYCERO 3 PHOSPHOCHOLINE; 1 OLEOYL 2 HYDROXY SN GLYCERO 3 PHOSPHOCHOLINE; 1 PALMITOYL 2 ARACHIDONOYL SN GLYCERO 3 PHOSPHOCHOLINE; 1 PALMITOYL 2 HYDROXY SN GLYCERO 3 PHOSPHOCHOLINE; 1 PALMITOYL 2 LINOLEOYL SN GLYCERO 3 PHOSPHOCHOLINE; 1 PALMITOYL 2 OLEOYL SN GLYCERO 3 PHOSPHOCHOLINE; 1 STEAROYL 2 ARACHIDONOYL SN GLYCERO 3 PHOSPHOCHOLINE; 1 STEAROYL 2 HYDROXY SN GLYCERO 3 PHOSPHOCHOLINE; 1 STEAROYL 2 LINOLEOYL SN GLYCERO 3 PHOSPHOCHOLINE; ARACHIDONIC ACID; HUMAN SERUM ALBUMIN; IMMUNOGLOBULIN G; LOW DENSITY LIPOPROTEIN; LYSOPHOSPHATIDYLCHOLINE; N HEPTADECANOYL DEXTRO ERYTHRO SPHINGOSYLPHOSPHORYLCHOLINE; N PALMITOYL DEXTRO ERYTHRO SPHINGOSYLPHOSPHORYLCHOLINE; OXIDIZED LOW DENSITY LIPOPROTEIN; PALMITIC ACID; PHOSPHOLIPID; SATURATED FATTY ACID; SPHINGOMYELIN; STEARIC ACID; UNCLASSIFIED DRUG;

ADULT; ARTICLE; FEMALE; GEL PERMEATION CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; IN VITRO STUDY; LIPID OXIDATION; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DETERMINATION; PROTEIN LIPID INTERACTION;

ADULT; ATHEROSCLEROSIS; CHROMATOGRAPHY, GEL; FATTY ACIDS, UNSATURATED; FEMALE; HUMANS; IMMUNOGLOBULIN G; LIPOPROTEINS, LDL; LYSOPHOSPHATIDYLCHOLINES; MALE; MIDDLE AGED; OXIDATION-REDUCTION; PHOSPHOLIPIDS; SERUM ALBUMIN; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; SPHINGOMYELINS;

EID: 80051475466     PISSN: 00093084     EISSN: 18732941     Source Type: Journal    
DOI: 10.1016/j.chemphyslip.2011.06.002     Document Type: Article

References (52)

1. M.A. Austin, M.C. King, K.M. Vranizan, and R.M. Krauss Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk Circulation 82 1990 495 506 (Pubitemid 20257828)
2. O. Belgacem Isolation of esterified fatty acids bound to serum albumin purified from human plasma and characterised by MALDI mass spectrometry Biologicals 35 2007 43 49
3. C.J. Binder, M.-K. Chang, P.X. Shaw, Y.I. Miller, K. Hartvigsen, A. Dewan, and J.L. Witztum Innate and acquired immunity in atherogenesis Nat. Med. 8 2002 1218 1226 (Pubitemid 35373552)
4. N. Brossard, M. Croset, S. Normand, J. Pousin, J. Lecerf, M. Laville, J.L. Tayot, and M. Lagarde Human plasma albumin transports [13C]docosahexaenoic acid in two lipid forms to blood cells J. Lipid Res. 38 1997 1571 1582 (Pubitemid 27427654)
5. J.A. Buege, and S.D. Aust Lactoperoxidase-catalyzed lipid peroxidation of microsomal and artifical membranes Biochim. Biophys. Acta 444 1976 192 201
6. M.J. Chapman, S. Goldstein, D. Lagrange, and P.M. Laplaud A density gradient ultracentrifugal procedure for the isolation of the major lipoprotein classes from human serum J. Lipid Res. 22 1981 339 358 (Pubitemid 11125137)
7. M. Croset, N. Brossard, A. Polette, and M. Lagarde Characterization of plasma unsaturated lysophosphatidylcholines in human and rat Biochem. J. 345 2000 61 67 (Pubitemid 30060104)
8. 2 in oxidized human low density lipoprotein J. Biol. Chem. 283 2008 6428 6437
9. H. Esterbauer, J. Gebicki, H. Puhl, and G. Jürgens The role of lipid peroxidation and antioxidants in oxidative modification of LDL Free Radic. Biol. Med. 13 1992 341 390
10. H. Esterbauer Continuous monitoring of in vitro oxidation of human low density lipoprotein Free Radic. Res. Commun. 6 1989 67 75 (Pubitemid 19109796)
11. B. Frei On the role of vitamin C and other antioxidants in atherogenesis and vascular dysfunction Proc. Soc. Exp. Biol. Med. 222 1999 196 204 (Pubitemid 129708634)
12. B. Frei, R. Stocker, and B.N. Ames Antioxidant defenses and lipid peroxidation in human blood plasma Proc. Natl. Acad. Sci. U.S.A. 85 1988 9748 9752 (Pubitemid 19027202)
13. A.M. Fogelman, I. Shechter, J. Seager, M. Hokom, J.S. Child, and P.A. Edwards Malondialdehyde alteration of low density lipoproteins leads to cholesteryl ester accumulation in human monocyte-macrophages PNAS 77 1980 2214 2218 (Pubitemid 10089629)
14. P. Friedman, S. Hörkkö, D. Steinberg, J.L. Witztum, and E.A. Dennis Correlation of antiphospholipid antibody recognition with the structure of synthetic oxidized phospholipids: importance of schiff base formation and aldol condensation J. Biol. Chem. 277 2002 7010 7020 (Pubitemid 34953088)
15. J. Galle, R. Schneider, A. Heinloth, C. Wanner, P.R. Galle, E. Conzelmann, S. Dimmeler, and K. Heermeier Lp(a) and LDL induce apoptosis in human endothelial cells and in rabbit aorta: role of oxidative stress Kidney Int. 55 1999 1450 1461 (Pubitemid 29157144)
16. J.L. Goldstein, Y.K. Ho, S.K. Basu, and M.S. Brown Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition Proc. Natl. Acad. Sci. U.S.A. 76 1977 333 337 (Pubitemid 9110191)
17. S. Guedes, R. Vitorino, R. Domingues, F. Amado, and P. Domingues Oxidation of bovine serum albumin: identification of oxidation products and structural modifications Rapid Commun. Mass Spectrom. 23 2009 2307 2315
18. B. Halliwell, and J.M.C. Gutteridge The antioxidants of human extracellular fluids Arch. Biochem. Biophys. 280 1990 1 8 (Pubitemid 20196526)
19. H. Hidaka, H. Noboru, M. Sugano, K. Kawasaki, K. Yamauchi, and T. Katsuyama Analysis of human serum lipoprotein lipid composition usind MALDI-TOF mass spectrometry Ann. Clin. Lab. Sci. 37 2007 213 221 (Pubitemid 47311337)
20. P. Holvoet, J. Vanhaecke, S. Janssens, F. Van de Werf, and D. Collen Oxidized LDL and malondialdehyde-modified LDL in patients with acute coronary syndromes and stable coronary artery disease Circulation 98 1998 1487 1494 (Pubitemid 28481664)
21. Y.-L. Kim, Y.-J. Im, N.-C. Ha, and D.-S. Im Albumin inhibits cytotoxic activity of lysophosphatidylcholine by direct binding Prostaglandins Other Lipid Mediat. 83 2007 130 138 (Pubitemid 46149407)
22. C. Koy, S. Mikkat, E. Raptakis, C. Sutton, M. Resch, K. Tanaka, and M.O. Glocker Matrix-assisted laser desorption/ionization-quadrupole ion trap-time of flight mass spectrometry sequencing resolves structures of unidentified peptides obtained by in-gel tryptic digestion of haptoglobin derivatives from human plasma proteomes Proteomics 3 2003 851 858 (Pubitemid 36801671)
23. R. Kulschar, B. Engelmann, C. Bräutigam, J. Duhm, J. Thiery, and W.O. Richter Fast transmission of alterations in plasma phosphatidylcholine/ spingomyelin ratio and lyso phosphatidylcholine levels into changes of red blood cell membrane phospholipid composition after low density lipoprotein apheresis Eur. J. Clin. Invest. 25 1995 258 265
24. S.Y. Liu, X. Lu, S. Choy, T.C. Dembinski, G.M. Hatch, D. Mymin, X. Shen, A. Angel, P.C. Choy, and R.Y. Man Alteration of lysophosphatidylcholine content in low density lipoprotein after oxidative modification: relationship to endothelium dependent relaxation Cardiovasc. Res. 28 1994 1476 1481 (Pubitemid 24318260)
25. R.L. Martin, and F.L. Brancia Analysis of high mass peptides using a novel matrix-assisted laser desorption/ionisation quadrupole ion trap time-of-flight mass spectrometer Rapid Commun. Mass Spectrom. 17 2003 1358 1365 (Pubitemid 36750021)
26. I. Maor, T. Hayek, R. Coleman, and M. Aviram Plasma LDL oxidation leads to its aggregation in the atherosclerotic apolipoprotein E-deficient mice Arterioscler. Thromb. Vasc. Biol. 17 1997 2995 3005 (Pubitemid 28016052)
27. L. Musante, M. Bruschi, G. Candiano, A. Petretto, N. Dimasi, P. Del Boccio, A. Urbani, G. Rialdi, and G.M. Ghiggeri Characterization of oxidation end product of plasma albumin 'in vivo' Biochem. Biophys. Res. Commun. 349 2006 668 673 (Pubitemid 44344568)
28. E.M. Oborina, and M.C. Yappert Effect of sphingomyelin versus dipalmitoylphosphatidylcholine on the extent of lipid oxidation Chem. Phys. Lipids 123 2003 223 232 (Pubitemid 36419534)
29. P. Ojala, M. Hermansson, M. Tolvanan, K. Polvinen, T. Hirvonen, U. Impola, M. Jauhiainen, P. Somerharju, and J. Parkkinen Identification of alpha-1 acid glycoprotein as a lysophospholipid binding protein: a complementary role to albumin in the scavenging of lysophosphatidylcholine Biochemistry 45 2006 14021 14031 (Pubitemid 44846191)
30. S. Parthasarathy, and J. Barnett Phospholipase A2 activity of low density lipoprotein: evidence for an intrinsic phospholipase A2 activity of apoprotein B-100 Proc. Natl. Acad. Sci. U.S.A. 87 1990 9741 9745 (Pubitemid 120016519)
31. D.V. Parums, D.L. Brown, and M.J. Mitchinson Serum antibodies to oxidized low-density lipoprotein and ceroid in chronic periaortitis Arch. Pathol. Lab. Med. 114 1990 383 387 (Pubitemid 20135843)
32. M. Petkovic, J. Müller, M. Müller, J. Schiller, K. Arnold, and J. Arnhold Application of matrix-assisted laser desorption/ionization time-of-flight mass spectrometry for monitoring the digestion of phosphatidylcholine by pancreatic phospholipase A(2) Anal. Biochem. 308 2002 61 70 (Pubitemid 35191637)
33. O.W. Portman, and M. Alexander Lysophosphatidylcholine concentrations and metabolism in aortic intima plus inner media: effect of nutritionally induced atherosclerosis J. Lipid Res. 10 1969 158 165
34. J. Quiao, F. Huang, R.P. Naikawadi, K.S. Kim, T. Said, and H. Lum Lysophosphatidylcholine impairs endothelial barrier function through the G protein-coupled receptor GPR4 Am. J. Physiol. 291 2006 L91 L101
35. A. Saifer, and L. Goldman The free fatty acids bound to human serum albumin J. Lipid Res. 2 1961 268 270
36. J.T. Salonen, S. Ylä-Herttuala, R. Yamamoto, S. Butler, H. Korpela, R. Salonen, K. Nyyssönen, W. Palinski, and J.L. Witztum Autoantibody against oxidised LDL and progression of carotid atherosclerosis Lancet 339 1992 883 887
37. 31P-NMR J. Lipid Res. 42 2001 1501 1508 (Pubitemid 34007682)
38. A. Schlitt, S. Blankenberg, D. Yan, H. von Gizycki, M. Buerke, K. Werdan, C. Bickel, K.J. Lackner, J. Meyer, H.J. Rupprecht, and X.-C. Jiang Further evaluation of plasma sphingomyelin levels as a risk factor for coronary artery disease Nutr. Metab. 3 2006 5 12
39. S. Schwitzer, and H.A. Eder Transport of lysolecithin by albumin in human and rat plasma J. Lipid Res. 6 1965 506 511
40. 2 and in diabetic patients: protection by nitric oxide donor Metabolism 52 2003 308 314 (Pubitemid 36401675)
41. K. Sonoki, M. Yoshinari, M. Iwase, K. Iino, K. Ichikawa, S. Ohdo, S. Higuchi, and M. Iida Glycoxidized low-density lipoprotein enhances monocyte chemoattractant protein-1 mRNA expression in human umbilical vein endothelial cells: relation to lysophosphatidylcholine contents and inhibition by nitric oxide donor Metabolism 51 2002 1135 1142
42. D. Steinberg Low density lipoprotein oxidation and its pathobiological significance J. Biol. Chem. 272 1997 20963 20966 (Pubitemid 27373946)
43. D. Steinberg The LDL modification hypothesis of atherogenesis: an update J. Lipid Res. 50 Suppl. 2009 S376 S381
44. U.P. Steinbrecher, S. Parthasarathy, D.S. Leake, J.L. Witztum, and D. Steinberg Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids Proc. Natl. Acad. Sci. U.S.A. 81 1984 3883 3887 (Pubitemid 14087823)
45. G. Stübiger, E. Pittenauer, O. Belgacem, P. Rehulka, K. Widhalm, and G. Allmaier Analysis of human plasma lipids and soybean lecithin by means of high-performance thin-layer chromatography and matrix-assisted laser desorption/ionization mass spectrometry Rapid Commun. Mass Spectrom. 23 2009 2711 2723
46. G. Stübiger, and O. Belgacem Analysis of lipids using 2,4,6-trihydroxyacetophenone as a matrix for MALDI mass spectrometry Anal. Chem. 79 2007 3206 3213 (Pubitemid 46640545)
47. G. Stübiger, M. Marchetti, M. Nagano, R. Grimm, G. Gmeiner, C. Reichel, and G. Allmaier Characterization of N- and O-glycopeptides of recombinant human erythropoietins as potential biomarkers for doping analysis by means of microscale sample purification combined with MALDI-TOF and quadrupole IT/RTOF mass spectrometry J. Sep. Sci. 28 2005 1764 1778 (Pubitemid 43055022)
48. G. Stubiger, G. Sobal, H. Montgomery, K. Widhalm, K. Pock, and O. Belgacem MALDI lipid profiling - novel approach for detection of dietary based changes of plasma lipids and molecular lipoprotein modifications Atheroscler. Suppl. 9 2008 157
49. 125I-LDL binding and MALDI-lipid profiling. Potential for atherosclerosis imaging? J. Nucl. Med. 48 2007 321P (47)
50. I. Tabas Nonoxidative modification of lipoprotein in atherosclerosis Annu. Rev. Nutr. 19 1999 123 139
51. A. Vila, W. Korytowski, and A.W. Girotti Spontaneous transfer of phospholipid and cholesterol hydroperoxides between cell membranes and low-density lipoprotein: assessment of reaction kinetics and prooxidant effects Biochemistry 41 2002 13705 13716 (Pubitemid 35332708)
52. Z. Zhou, J. Luchoomun, A. Bakillah, and M.M. Hussain Lysophosphatidylcholine increases apolipoprotein B secretion by enhancing lipid synthesis and decreasing its intracellular degradation in HepG2 cells Biochim. Biophys. Acta 1391 1998 13 24 (Pubitemid 28143971)